Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma

NCT01556815 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

PHENYTOIN/SORAFENIB [VA Drug Interaction]
Liver Neoplasms
Carcinoma, Hepatocellular
Digestive System Neoplasms
Neoplasms by Site
Liver Diseases
Adenocarcinoma
Carcinoma
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
DOXORUBICIN/TRASTUZUMAB [VA Drug Interaction]
HBV

Interventions

PROCEDURE: Transarterial Chemoembolization (TACE)
OTHER: Sorafenib in combination with TACE

Sponsor

Shandong Cancer Hospital and Institute